PMID: 7214397Sep 1, 1980Paper

Furosemide-induced thiamine deficiency

Cardiovascular Research
Y YuiC Kawai


Male Wistar rats were separated into 4 groups: group 1, thiamine sufficient diet (control); group 2, thiamine sufficient diet with intraperitoneal administration of furosemide (20 mg . kg-1 of body weight); group 3, thiamine deficient diet; group 4, thiamine deficient diet within tra-peritoneal administration of furosemide. After 4 weeks, the rats were killed and the thiamine levels and activity of transketolase were assayed. Thiamine concentration and transketolase activity were significantly decreased and thiamine pyrophosphate effect was significantly increased in the blood, and various tissues in group 2 and 4 compared with group 1 and 3, respectively. The intraperitoneal administration of various concentrations of furosemide (20 mg, 10 mg, and 2 mg . kg-1 of body weight) resulted in a significant increase in urinary thiamine excretion. Thus, it is assumed that long-term administration of furosemide could induce a thiamine deficiency.


May 1, 1995·Journal of the American Dietetic Association·J A BradyM R Horneffer
Dec 16, 1998·European Journal of Pharmacology·A ZangenA Shainberg
Sep 11, 1999·The Journal of Laboratory and Clinical Medicine·C S Wilcox
Aug 7, 2002·International Journal of Cardiology·Klaus K A Witte, A L Clark
Jun 13, 2001·Journal of the American College of Cardiology·K K WitteJ G Cleland
Jun 19, 2003·Journal of the American Medical Directors Association·R C Buxbaum, M Yurkofsky
Dec 14, 1985·British Medical Journal·S H Anderson, T J Charles
Nov 8, 2011·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Andreas W SchoenenbergerPaul Erne
Aug 12, 2014·Case Reports in Cardiology·Naoki MisumidaMitsunori Iwase
Nov 3, 1998·The British Journal of Nutrition·S E Gariballa, A J Sinclair
Feb 24, 2016·The American Journal of Medicine·Natraj KattaMartin A Alpert
Nov 16, 2007·The American Journal of the Medical Sciences·Takeshi TsujinoTohru Masuyama
Jan 9, 2014·Life Sciences·Danilo Roman-Campos, Jader Santos Cruz
Nov 13, 2007·Journal of Cardiac Failure·Sergio da CunhaCarlos Alberto Mandarim-de-Lacerda
Dec 24, 2015·Case Reports in Neurological Medicine·Nuria Huertas-GonzálezJuan Luis Cervera-Rodilla
Aug 4, 2007·Congestive Heart Failure·Domenic A Sica
Aug 6, 2013·Congestive Heart Failure·James J DiNicolantonioHector O Ventura
Oct 23, 1997·Biochemical Pharmacology·A Zangen, A Shainberg
Jun 1, 1996·American Heart Journal·D Leslie, Mihai Gheorghiade
Sep 11, 1999·The Journal of Laboratory and Clinical Medicine·A LubetskyD Ezra
Sep 11, 1999·The Journal of Laboratory and Clinical Medicine·J RieckD Ezra
Sep 1, 1984·Progress in Cardiovascular Diseases·W H Abelmann
Oct 2, 2008·The Journal of Toxicological Sciences·Yuka KohdaTakao Tanaka
Oct 24, 2009·Journal of the American College of Cardiology·Victor SoukoulisMihai Gheorghiade
Jan 18, 2006·Journal of the American College of Cardiology·Stacy A HanninenMary E Keith
Jun 22, 2000·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·B H Ali, A A Al-Qarawi
Mar 7, 2014·Journal of Nutrition in Gerontology and Geriatrics·Afshin NazmiGeoffrey Maxwell Robinson
Jul 6, 2016·Frontiers in Nutrition·Laurent HifflerDaniel Martinez Garcia
Jul 28, 2016·Nutrients·Edoardo SciattiMarco Metra
Jan 24, 2004·Journal of Cardiovascular Pharmacology and Therapeutics·Cesar E MendozaDonald G Rosenberg
Jun 13, 2000·JPEN. Journal of Parenteral and Enteral Nutrition·R ShamirG Dinari
Oct 14, 2008·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Jennifer A Wooley
Dec 14, 1985·British Medical Journal·P R Hunter, C D Ribeiro
Dec 14, 1985·British Medical Journal·R J Buist
Sep 22, 2011·Expert Review of Cardiovascular Therapy·Victor Marinescu, Peter A McCullough
Nov 21, 2000·Current Opinion in Clinical Nutrition and Metabolic Care·M J Sole, K N Jeejeebhoy
Sep 13, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Takao TanakaYasushi Kitaura
Feb 13, 2021·Annals of the New York Academy of Sciences·Filomena GomesPhilip R Fischer

Related Concepts

Enzyme Activation
Salix - substance
Thiamine Mononitrate
Thiamine Deficiency

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Generating Insulin-Secreting Cells

Reprogramming cells or using induced pluripotent stem cells to generate insulin-secreting cells has significant therapeutic implications for diabetics. Here is the latest research on generation of insulin-secreting cells.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Epigenome Editing

Epigenome editing is the directed modification of epigenetic marks on chromatin at specified loci. This tool has many applications in research as well as in the clinic. Find the latest research on epigenome editing here.